Literature DB >> 7253344

Specific binding of 125I-salmon calcitonin to rat brain: regional variation and calcitonin specificity.

H Nakamuta, S Furukawa, M Koida, H Yajima, R C Orlowski, R Schlueter.   

Abstract

Rat brain particulate fraction was found to contain binding sites for 125I-Salmon Calcitonin-I (125I-SCT). Maximum binding occurred in the physiological pH range of 7.25-7.5. The binding reaction proceeded in a temperature-dependent manner. Binding sites were broadly distributed among the various rat brain regions and considerable regional differences existed in the affinity and density as detected by Scatchard analysis. The highest affinity was recorded in the case of the hypothalamus and the lowest in the case of the cerebellum. The KD (nM) and Bmax (pmole/mg protein) estimated for the binding to four regions were as follows: hypothalamus: 1.4 and 0.19, midbrain, hippocampus plus striatum: 1.5 and 0.08, pons plus medulla oblongata: 3.0 and 0.15 and cerebellum: 8.3 and 0.20. Using a particulate fraction of rat brain void of cerebellum and cortices, a binding assay for calcitonins was developed. Binding of 125I-SCT was inhibited by unlabeled salmon, [Asu1,7]-eel and porcine calcitonins in a dose-dependent manner and the IC50s were 2.0, 8.0 and 30 nM, respectively. The IC50s were comparable to those estimated using a kidney particulate fraction. Human calcitonin, beta-endorphin and substance P were weak inhibitors of the binding. Other peptides, drugs and putative neurotransmitters tested (totally 23 substances) failed to inhibit the binding at concentrations of 1.0 microM. The physiological significance of brain binding sites for calcitonin, with the possibility that the brain may possess endogenous ligands for these sites are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7253344     DOI: 10.1254/jjp.31.53

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  7 in total

1.  Biological and physical properties of a model calcitonin containing a glutamate residue interrupting the hydrophobic face of the idealized amphiphilic alpha-helical region.

Authors:  F R Green; B Lynch; E T Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 2.  Central nervous system binding sites for calcitonin and calcitonin gene-related peptide.

Authors:  P M Sexton
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Calcitonin suppresses growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man.

Authors:  A M Lengyel; A L Toledo; M A Czepielewski; J G Vieira; A R Chacra
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

4.  Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary.

Authors:  J A Fischer; P H Tobler; M Kaufmann; W Born; H Henke; P E Cooper; S M Sagar; J B Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

Review 5.  Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992.

Authors:  P C Braga
Journal:  Agents Actions       Date:  1994-05

6.  Human placental calcitonin receptors.

Authors:  G C Nicholson; C S D'Santos; T Evans; J M Moseley; B E Kemp; V P Michelangeli; T J Martin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

7.  Inhibitory effects of salmon calcitonin on the tail-biting and scratching behavior induced by substance P and three excitatory amino acids.

Authors:  Y Maeda; K Yamada; T Hasegawa; M Iyo; S Fukui; T Nabeshima
Journal:  J Neural Transm Gen Sect       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.